Skip to main content
Log in

Current Antidepressant Drugs: Their Clinical Use

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Depression is not only a common disorder, but also one that is readily treatable. Antidepressant drugs play a major role in treatment, although concurrent use of electroconvulsive therapy or psychotherapy may be indicated for some patients. Antidepressant drugs have been most specifically beneficial for patients with ‘endogenous’ depressions, but they should be used whenever this type of depression cannot be definitely ruled out. Besides the older tricyclic anti-depressants and monoamine oxidase inhibitors, a new ‘second generation’ group of drugs is now available. Although these drugs offer no great therapeutic advantages over the older ones, they may prove to have a more acceptable profile of side effects, may act more quickly, and may show less cardiotoxicity with overdoses. Whether one can classify depression pathogenetically according to various biological markers, such as urinary excretion of the norepinephrine metabolite, 3-methoxy-4-hydroxy phenylglycol, is still uncertain. At present, the choice of antidepressant drug for an individual patient is largely empirical. Besides being useful for treating depression, antidepressants may be used for treating enuresis, chronically painful states, obsessive-compulsive-phobic states, acute panic attacks and cataplectic attacks in narcoleptics.

Many studies have tried to define a therapeutic range of plasma concentrations of these drugs, so as to afford a better basis for dosing, but routine monitoring of drug plasma concentrations is seldom needed; the primary indication for doing so would be in the patient who has received what should be an adequate dose but who is still unresponsive. The value of maintenance treatment with antidepressants has been clearly established; the pattern it takes is best determined by the natural history of the disorder in individual patients.

Most drug interactions with antidepressants are pharmacodynamic in nature and can be managed by adjusting doses. Pharmacokinetic interactions with various sympatholytic antihypertensive drugs, such as guanethidine, methyldopa and clonidine, are rare but may be serious.

Patients with depression may be spared a considerable amount of discomfort, morbidity, and possibly mortality, by judicious use of antidepressant drugs and the other treatments currently available.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Aberg, A. and Holmberg, G.: Preliminary clinical test of zimelidine (H 102/09), a new 5-HT uptake inhibitor. Acta Psychiatrica Scandinavica 59: 45–58 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Alkalay, D.; Wagner, W.E. Jr; Carlsen, S.; Khemani, L.; Volk, J.; Bartlett, F. and LeSher, A.: Bioavailability and kinetics of maprotiline. Clinical Pharmacology and Therapeutics 27: 697–703 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Alvan, G.; Borga, O.; Lind, M.; Palmer, L. and Siwers, B.: First pass hydroxylation of nortriptyline: concentrations of parent drug and metabolites in plasma. European Journal of Clinical Pharmacology 11: 219–224 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Amsterdam, J.; Brunswick, D.J. and Mendels, J.: High dose desipramine, plasma drug levels and clinical response. Journal of Clinical Psychiatry 40: 141–143 (1979).

    PubMed  CAS  Google Scholar 

  • Bannerjee, S.P.; Kung, L.S.; Riggi, S.J. and Ghanda, S.K.: Development of β-adrenergic receptor subsensitivity by anti-depressants. Nature 268: 455–456 (1977).

    Article  Google Scholar 

  • Beckman, H. and Goodwin, F.K.: Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Archives of General Psychiatry 32: 17–21 (1975).

    Article  Google Scholar 

  • Bigger, J.T. Jr.; Giardina, E.G.V.; Perel, J.M.; Kantor, S.J. and Glassman, A.H.: Cardiac antiarrhythmic effect of imipramine hydrochloride. New England Journal of Medicine 296: 206–208 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Biggs, J.T. and Ziegler, V.E.: Protriptyline plasma levels and clinical response. Clinical Pharmacology and Therapeutics 22: 269–273 (1977).

    PubMed  CAS  Google Scholar 

  • Bopp, B. and Biel, J.H.: Antidepressant drugs. Life Sciences 14: 415–423 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Braithwaite, R.A.; Goulding, R.; Theano, G.; Bailey, J. and Coppen, A.: Plasma concentration of amitriptyline and clinical response. Lancet 1: 1297–1300 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Brogden, R.N.; Heel, R.C.; Speight, T.M. and Avery, G.S.: Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs 16: 273–301 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Brogden, R.N.; Heel, R.C.; Speight, T.M. and Avery, G.S.: Nomifensine: A review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs 18: 1–24 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Brogden, R.N.; Heel, R.C.; Speight, T.M. and Avery, G.S.: Trazodone: A review of its pharmacological properties and therapeutic efficacy in depression. Drugs 21: 401–429 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Carasso, R.L.; Yehuda, S. and Streifler, M.: Clomipramine and amitriptyline in the treatment of severe pain. International Journal of Neuroscience 9: 191–194 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Casarino, J.P.: Neuropathy associated with amitriptyline. New York State Journal of Medicine 77: 2124–2126 (1977).

    PubMed  CAS  Google Scholar 

  • Chermat, R.; Simon, P. and Boissier, J.R.: Amoxapine in experimental psychopathology: A neuroleptic or an antidepressant. Arzneimittel-Forschung 29: 814–820 (1979).

    PubMed  CAS  Google Scholar 

  • Coppen, A.; Ghose, K.; Montgomery, S.; Rama Rao, V.A.; Bailey, J. and Jorgensen, A.: Continuation therapy with amitriptyline in depression. British Journal of Psychiatry 133: 28–33 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Crombie, D.L.; Pensent, R.J. and Fleming, D.: Imipramine in pregnancy. British Medical Journal 1: 745 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Davidson, J.; McLeod, M.N. and White, H.L.: Inhibition of platelet monoamine oxidase in depressed subjects treated with phenelzine. American Journal of Psychiatry 135: 470–472 (1978).

    PubMed  CAS  Google Scholar 

  • Davies, R.K.; Tucker, G.J.; Harrow, M. et al.: Confusional episodes and antidepressant medication. American Journal of Psychiatry 128: 127–131 (1971).

    Google Scholar 

  • Davis, J.M.: Overview: maintenance therapy in psychiatry. II. Affective disorders. American Journal of Psychiatry 133: 1–13 (1976).

    PubMed  CAS  Google Scholar 

  • Davis, J.L.; Lewis, S.B.; Gerich, J.E.; Kaplan, R.A.; Schultz, T.A. and Wallin, J.D.: Peripheral diabetic neuropathy treated with amitriptyline and fluphenazine. Journal of the American Medical Association 238: 2291–2292 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Dawling, S.; Braithwaite, R.A.; McAuley, R. and Montgomery, S.A.: Single oral dose pharmacokinetics of clomipramine in depressed patients. Postgraduate Medical Journal 56(Suppl. 1): 115–116 (1980).

    PubMed  Google Scholar 

  • Della Corte, L; Broadhurst, A.D.; Sgaragli, G.P.; Filippini, S.; Heeley, A.F.; James, H.D.; Faravelli, C. and Pazzagli, A.: A clinical response and tricyclic plasma levels during treatment with clomopramine. British Journal of Psychiatry 134: 390–400 (1979).

    Article  PubMed  Google Scholar 

  • Fabre, L.F. and McLendon, D.M.: A double-blind study comparing the efficacy and safety of alprazolam with imipramine and placebo in primary depression. Current Therapeutic Research 27: 474–482 (1980).

    Google Scholar 

  • Fann, W.E.; Cavanaugh, J.H.; Kaufmann, J.S.: Doxepin: Effects on transport of biogenic amines in man. Psychopharmacologia 22: 111–125 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Garver, D.L. and Davis, J.M.: Biogenic amine hypothesis of affective disorders. Life Sciences 24: 383–394 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Georgotas, A.; Mann, J.; Bush, D. and Gershon, S.: A clinical trial of zimelidine in depression. Communications in Psychopharmacology 4: 71–77 (1980).

    PubMed  CAS  Google Scholar 

  • Gershon, Rickels and Silvestrini (Eds) Trazodone: A new Broad-Spectrum A ntidepressant. Proceedings of a Symposium held in Vienna, during the 11th Congress of the Collegium Internationale Neuro-Psychopharmacologicum, July 9th–14th, 1978 (Excerpta Medica, Amsterdam 1980).

    Google Scholar 

  • Glassman, A.H.; Perel, J.M. and Shostak, M.: Clinical implications of imipramine plasma levels for depressive illness. Archives of General Psychiatry 34: 197–204 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Gram, L.F. and Christiansen, J.: First pass metabolism of imipramine in man. Clinical Pharmacology and Therapeutics 17: 555–563 (1975).

    PubMed  CAS  Google Scholar 

  • Gram, L.F.; Christiansen, J. and Overo, K.F.: Pharmacokinetic interaction between tricyclic antidepressants and other psychopharmaca. Acta Psychiatrica Scandinavica 243 (Suppl): 52–53 (1973).

    Article  Google Scholar 

  • Gram, L.F. and Overo, K.F.: First-pass metabolism of nortriptyline in man. Clinical Pharmacology and Therapeutics 18: 305–314 (1975).

    PubMed  CAS  Google Scholar 

  • Granacher, R.P. and Baldessarini, R.J.: Physostigmine. Its use in acute anticholinergic syndrome with antidepressant and anti-Parkinsonian drugs. Archives of General Psychiatry 32: 375–380 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Heiman, E.M.: Cardiac toxicity of thioridazine-tricyclic antidepressant combination. Journal of Nervous and Mental Disease 165: 139–143 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Hekimian, L.J.; Friefhoff, A.J. and Deever, E.: A comparison of the onset of action and therapeutic efficacy of amoxapine and amitriptyline. Journal of Clinical Psychiatry 39: 633–637 (1978).

    PubMed  CAS  Google Scholar 

  • Hollister, L.E.: Treatment of depression with drugs. Annals of Internal Medicine 89: 78–84 (1978).

    PubMed  CAS  Google Scholar 

  • Hollister, L.E.: Monitoring tricyclic antidepressant plasma concentrations. Journal of the American Medical Association 241: 2530–2533 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Hollister, L.E.; Overall, J.E.; Pokorny, A.D. and Shelton, J.: Acetophenazine and diazepam in anxious depressions. Archives of General Psychiatry 24: 273–278 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Hollister, L.E.; David, K.L.; Overall, J.E. and Anderson, T.: Excretion of MHPG in normal subjects. Implications for biological classification of affective disorders. Archives of General Psychiatry 35: 1410–1415 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Hollister, L.E.; Pfefferbaum, A. and Davis, K.L.: Monitoring nortriptyline plasma concentrations. American Journal of Psychiatry 137: 485–486 (1980).

    PubMed  CAS  Google Scholar 

  • Hordern, A. and Wheatley, D.: The black cloud: the recognition and treatment of endogenous depression in general practice. Medical Journal of Australia 1: 637–643 (1972).

    PubMed  CAS  Google Scholar 

  • Hrdina, P.D.; Rovei, V.; Henry, J.F.; Hervy, M.P.; Gomeni, R.; Forette, F. and Morselli, P.L.: Comparison of single-dose pharmacokinetics of imipramine and maprotiline in the elderly. Psychopharmacology 70: 29–34 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Jaffe, K. and Ziscook, S.: Galactorrhea in a patient treated with amoxapine. Journal of Clinical Psychiatry 39: 821 (1978).

    PubMed  CAS  Google Scholar 

  • Johnson, D.A.W.: A study of the use of antidepressant medication in general practice. British Journal of Psychiatry 125: 186–192 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Kass, E.J.; Diokno, A.C. and Montealegre, A.: Enuresis: Principles of management and result of treatment. Journal of Urology 121: 794–796 (1979).

    PubMed  CAS  Google Scholar 

  • Kiloh, LG.; Andrews, G.; Neilson, M. and Bianchi, G.N.: The relationship of the syndromes called endogenous and neurotic depression. British Journal of Psychiatry 121: 193–196 (1972).

    Article  Google Scholar 

  • Kotin, J.; Post, R.M. and Goodwin, F.K.: Drug treatment of depressed patients referred for hospitalization. American Journal of Psychiatry 130: 1139–1141 (1973).

    PubMed  CAS  Google Scholar 

  • Kragh-Sorensen, P.; Hvidberg, E.F.; Hansen, C.E. and Baastrup, P.C.: Therapeutic control of plasma concentrations and long-term effect of nortriptyline in recurrent affective disorders. Pharmakipsychiatrie Neuropsychopharmakologie 9: 178–182 (1976a).

    CAS  Google Scholar 

  • Kragh-Sorensen, P.; Hansen, C.E.; Baastrup, P.C. and Hvidberg, E.F.: Self-inhibiting action of nortriptyline’s antidepressive effect at high plasma levels. Psychopharmacologia 45: 305–312 (1976b).

    Article  PubMed  CAS  Google Scholar 

  • Kupfer, D.J.; Hanin, I.; Spiker, D.G.; Grau, T. and Coble, P.: Amitriptyline plasma levels and clinical response in primary depression. Clinical Pharmacology and Therapeutics 22: 904–911 (1977).

    PubMed  CAS  Google Scholar 

  • Luzecky, M.H.; Burman, K.D. and Schultz, E.R.: The syndrome of inappropriate secretion of antidiuretic hormone associated with amitriptyline administration. Southern Medical Journal 67: 495–497 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Maas, J.W.: Biogenic amines and depression. Archives of General Psychiatry 32: 1367–1371 (1975).

    Article  Google Scholar 

  • Messiha, F.S. and Morgan, J.P.: Imipramine-mediated effects on levodopa metabolism in man. Biochemical Pharmacology 23: 1503–1507 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Moir, DC; Cornwell, W.B.; Fordyce, I.D.; Crooks, J.; O’Malley, K. and Turnbull, M.J.: Cardiotoxicity of amitriptyline. Lancet 2: 561–564 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Morris, J.B. and Beck, A.T.: The efficacy of antidepressant drugs. Archives of General Psychiatry 30: 667–674 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Morrow, A.W.: Limb deformities associated with iminodibenzyl hydrochloride. Medical Journal of Australia 1: 658–659 (1972).

    PubMed  CAS  Google Scholar 

  • Montgomery, S.; Braithwaite, R.; Dawling, S. and McAuley, R.: High plasma nortriptyline levels in the treatment of depression. Clinical Pharmacology and Therapeutics 23: 309–314 (1978).

    PubMed  CAS  Google Scholar 

  • Montgomery, S.A.; McAuley, R.; Rani, S.J.; Montgomery, D.B.; Braithwaite, R. and Dawling, S.: Amitriptyline plasma concentration and clinical response. British Medical Journal 1: 230–231 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Moody, J.P.; Whyte, S.F.; MacDonald, A.J. and Maylor, G.J.: Pharmacokinetic aspects of protriptyline plasma levels. European Journal of Clinical Pharmacology 11: 51–56 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Nagy, A. and Johansson, R.: The demethylation of imipramine and clomipramine as apparent from their plasma kinetics. Psychopharmacology 54: 125–131 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Newton, R.W.: Physostigmine salicylate in the treatment of tricyclic antidepressant overdosage. Journal of the American Medical Association 231: 941–943 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Nies, A.; Robinson, D.S.; Friedman, M.J.; Green, R.; Cooper, T.B.; Ravaris, C.L. and Ives, J.O.: Relationship between age and tricyclic antidepressant levels. American Journal of Psychiatry 134: 790 (1977).

    PubMed  CAS  Google Scholar 

  • Overo, K.F.; Gram, L.F. and Hansen, V.: Kinetics of nortriptyline in man according to a two compartment model. European Journal of Clinical Pharmacology 8: 343–347 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Paykel, E.S.; Mueller, P.S. and de la Vergne, P.M.: Amitriptyline. weight gain and carbohydrate craving: a side effect. British Journal of Psychiatry 123: 501–507 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Pinder, R.M.; Brogden, R.N.; Speight, T.M. and Avery, G.S.: Maprotiline: a review of its pharmacological properties and therapeutic efficacy in mental depressive states. Drugs 13: 321–352 (1977a).

    Article  PubMed  CAS  Google Scholar 

  • Pinder, R.M.; Brogden, R.N.; Speight, T.M. and Avery, G.S.: Viloxazine: a review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs 13: 401–421 (1977b).

    Article  PubMed  CAS  Google Scholar 

  • Potter, W.Z.; Muscettola, G. and Goodwin, F.K.: Binding of imipramine to plasma protein and to brain tissue: relationship to CSF tricyclic levels in man. Psychopharmacology 63: 187–192 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Prien, R.F.; Klett, C.J. and Caffey, E.M. Jr.: Lithium carbonate and imipramine in prevention of affective episodes. Archives of General Psychiatry 29: 420–425 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Reisby, N.; Gram, L.F.; Bech, P.; Nagy, A.; Odden Petersen, G.; Ortmann, J.; Ibsen, I.; Dencker, S.J.; Jacobsen, O.; Krautwald, O.; Sondergaard, I. and Christiansen, J.: Clinical effects of pharmacokinetic variability. Psychopharmacology 54: 263–272 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Risch, S.C.; Huey, L.Y. and Jenowsky, D.S.: Plasma levels of tricyclic antidepressants and clinical efficacy: Review of the literature — Part 1. Journal of Clinical Psychiatry 40: 4–16 (1979).

    Google Scholar 

  • Robinson, D.S. and Barker, E.: Tricyclic antidepressant cardiotoxicity. Journal of the American Medical Association 236: 2089–2090 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Robinson, D.S.; Nies, A.; Ravaris, C.L. and Lamborn, K.R.: The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive-anxiety states: a controlled clinical trial. Archives of General Psychiatry 29: 407–413 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Rogers, S.C. and Clay, P.M.: A statistical review of controlled trials of imipramine and placebo in the treatment of depressive illness. British Journal of Psychiatry 127: 599–603 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Sathanathan, G.L and Gershon, S.: Imipramine withdrawal: an akathisia-like syndrome. American Journal of Psychiatry 130: 1286–1287 (1973).

    Google Scholar 

  • Schildkraut, J.J.: Toward a biochemical classification of depressive disorders: I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depression. Archives of General Psychiatry 35: 1427–1433 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Schiesser, M.A.; Winokur, G. and Sherman, B.M.: Genetic subtypes of unipolar primary depressive illness distinguished by hypothalamic-pituitary-adrenal axis activity. Lancet 1: 739–741 (1979).

    Article  Google Scholar 

  • Sethna, E.R.: A study of refractory cases of depressive illness and their response to combined antidepressant treatment. British Journal of Psychiatry 124: 265–273 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Shaw, D.M.: The practical management of affective disorders. British Journal of Psychiatry 130: 432–451 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Simon, P.; LeCrubier, Y.; Jouvent, J.; Puech, A.J.; Allilaire, J.F. and Widlöcher, D.: Experimental and clinical evidence of the antidepressant effect of a beta-adrenergic stimulant. Psychological Medicine 8: 335–338 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Sjoqvist, F.: Clinical use of drug plasma level determinations; in Azarnoff, Hollister and Shand (Eds) 1977 Yearbook of Drug Therapy, pp. 13–20 (Year Book Medical Publishers, Chicago 1977).

    Google Scholar 

  • Sorensen, B.; Kragh-Sorensen, P.; Larsen, N-E. and Hvidberg, E.F.: The practical significance of nortriptyline plasma control. Psychopharmacology 59: 35–39 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Stein, M.K.; Rickeis, K. and Wiese, C.C.: Maintenance therapy with amitriptyline: a controlled trial. American Journal of Psychiatry 137: 370–371 (1980).

    PubMed  CAS  Google Scholar 

  • Stern, S.L.; Rush, A.J. and Mendels, J.: Toward a rational pharmacotherapy of depression. American Journal of Psychiatry 137: 545–552 (1980a).

    PubMed  CAS  Google Scholar 

  • Stern, R.S.; Marks, I.M.; Wright, J. and Luscombe, D.K.: Clomipramine: plasma levels, side effects and outcome in obsessive-compulsive neurosis. Postgraduate Medical Journal 56(Suppl. 1): 134–139 (1980b).

    PubMed  Google Scholar 

  • Stewart, M.A.: Treatment of bedwetting. Journal of the American Medical Association 232: 281–283 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Vandel, S.; Vandel, B.; Sandoz, M.; Allers, G.; Bechlel, P. and Volmat, R.: Clinical response and plasma concentration of amitriptyline and its metabolite nortriptyline. European Journal of Clinical Pharmacology 14: 185–190 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Vetulani, J. and Sulser, F.: Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain. Nature 257: 495–496 (1975).

    Article  PubMed  CAS  Google Scholar 

  • van Spanning, H.W. and van Zwiewten, P.A.: The interference of tricyclic antidepressants with the central hypotensive effect of clonidine. European Journal of Pharmacology 24: 402–404 (1973).

    Article  PubMed  Google Scholar 

  • Wilson, I.C.; Loosen, P.T.; Pettus, C.W.: A double-blind clinical comparison of amoxapine, imipramine and placebo in the treatment of depression. Current Therapeutic Research, Clinical and Experimental 22: 620–627 (1977).

    Google Scholar 

  • Ziegler, V.E.; Co, B.T.; Taylor, J.R.; Clayton, P.J. and Biggs, J.T.: Amitriptyline plasma levels and therapeutic response. Clinical Pharmacology and Therapeutics 19: 795–801 (1976).

    PubMed  CAS  Google Scholar 

  • Ziegler, V.E.; Biggs, J.T.; Ardekani, A.B. and Rosen, S.H.: Contribution to the pharmacokinetics of amitriptyline. Journal of Clinical Pharmacology 18: 462–467 (1978a).

    PubMed  CAS  Google Scholar 

  • Ziegler, V.E.; Biggs, J.T.; Wylie, L.T.; Rosen, S.H.; Hawf, DJ. and Coryell, W.H.: Doxepin kinetics. Clinical Pharmacology and Therapeutics 23: 573–579 (1978b).

    PubMed  CAS  Google Scholar 

  • Zis, A.P. and Goodwin, F.W.: Novel antidepressants and the biogenic amine hypothesis of depression. The case for iprindole and mianserin. Archives of General Psychiatry 36: 1097–1107 (1979).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hollister, L.E. Current Antidepressant Drugs: Their Clinical Use. Drugs 22, 129–152 (1981). https://doi.org/10.2165/00003495-198122020-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198122020-00003

Keywords

Navigation